Home V-Wave

V-Wave

acquired
Series C
Developer of Percutaneous Implantable Devices

Basic Information

The company is committed to developing percutaneous implantable devices for treating patients with chronic heart failure (HF). As a leading cause of death and hospitalization, HF continues to affect millions of people worldwide. V-Wave’s vision is to assist patients who still suffer from disabling symptoms or require hospitalization.
V-Wave Ltd.
Ramla,CentralDistrict,Israel
15~50 people
January 01, 2010
info@vwavemedical.com